These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 10955120)

  • 1. [Uterine papillary serous carcinoma--a different kind of tumor].
    Steinman N; Avni A
    Harefuah; 1999 May; 136(10):810-2. PubMed ID: 10955120
    [No Abstract]   [Full Text] [Related]  

  • 2. Human kallikrein 6: a new potential serum biomarker for uterine serous papillary cancer.
    Santin AD; Diamandis EP; Bellone S; Soosaipillai A; Cane S; Palmieri M; Burnett A; Roman JJ; Pecorelli S
    Clin Cancer Res; 2005 May; 11(9):3320-5. PubMed ID: 15867230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microarray analysis of endometrial carcinomas and mixed mullerian tumors reveals distinct gene expression profiles associated with different histologic types of uterine cancer.
    Maxwell GL; Chandramouli GV; Dainty L; Litzi TJ; Berchuck A; Barrett JC; Risinger JI
    Clin Cancer Res; 2005 Jun; 11(11):4056-66. PubMed ID: 15930340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical significance of Her-2/neu status in patients with uterine papillary serous carcinoma].
    Ren YL; Wang HY; Zhou XY; Shan BE; Yang WT; Shen L; Shi DR
    Zhonghua Fu Chan Ke Za Zhi; 2010 May; 45(5):367-71. PubMed ID: 20646447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective, non-randomized phase 2 clinical trial of carboplatin plus paclitaxel with sequential radical pelvic radiotherapy for uterine papillary serous carcinoma.
    Obermair A; Mileshkin L; Bolz K; Kondalsamy-Chennakesavan S; Cheuk R; Vasey P; Wyld D; Goh J; Nicklin JL; Perrin LC; Sykes P; Janda M
    Gynecol Oncol; 2011 Feb; 120(2):179-84. PubMed ID: 21126755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRCA2 germline mutation in a woman with uterine serous papillary carcinoma--case report.
    Lavie O; Ben-Arie A; Pilip A; Rennert G; Cohen Y; Feiner B; Auslnader R
    Gynecol Oncol; 2005 Nov; 99(2):486-8. PubMed ID: 16051327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uterine papillary serous carcinoma: what have we learned over the past quarter century?
    Goff BA
    Gynecol Oncol; 2005 Sep; 98(3):341-3. PubMed ID: 16111527
    [No Abstract]   [Full Text] [Related]  

  • 8. Overexpression of claudin-3 and claudin-4 receptors in uterine serous papillary carcinoma: novel targets for a type-specific therapy using Clostridium perfringens enterotoxin (CPE).
    Santin AD; Bellone S; Marizzoni M; Palmieri M; Siegel ER; McKenney JK; Hennings L; Comper F; Bandiera E; Pecorelli S
    Cancer; 2007 Apr; 109(7):1312-22. PubMed ID: 17326053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete response of a stage IV uterine papillary serous carcinoma to neoadjuvant chemotherapy with Taxol and carboplatin.
    Le TD; Yamada SD; Rutgers JL; DiSaia PJ
    Gynecol Oncol; 1999 Jun; 73(3):461-3. PubMed ID: 10366480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Papillary serous carcinoma of the peritoneum coexisting with or after endometrial carcinoma.
    Altaras MM; Bernheim J; Zehavi T; Drucker L; Uziel O; Fishman A
    Gynecol Oncol; 2002 Feb; 84(2):245-51. PubMed ID: 11812082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Precursor lesions of type II endometrial cancer: diagnostic criteria and pathogenesis].
    Wang HJ; Zheng WX
    Zhonghua Bing Li Xue Za Zhi; 2007 Aug; 36(8):505-7. PubMed ID: 17980094
    [No Abstract]   [Full Text] [Related]  

  • 12. Uterine papillary serous carcinoma: a new paradigm for treatment?
    Annunziata CM; Kotz HL
    Cancer; 2009 Aug; 115(16):3594-6. PubMed ID: 19452535
    [No Abstract]   [Full Text] [Related]  

  • 13. High serum levels of interleukin-6 in endometrial carcinoma are associated with uterine serous papillary histology, a highly aggressive and chemotherapy-resistant variant of endometrial cancer.
    Bellone S; Watts K; Cane' S; Palmieri M; Cannon MJ; Burnett A; Roman JJ; Pecorelli S; Santin AD
    Gynecol Oncol; 2005 Jul; 98(1):92-8. PubMed ID: 15904949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pilot phase II trial of radiation "sandwiched" between combination paclitaxel/platinum chemotherapy in patients with uterine papillary serous carcinoma (UPSC).
    Fields AL; Einstein MH; Novetsky AP; Gebb J; Goldberg GL
    Gynecol Oncol; 2008 Jan; 108(1):201-6. PubMed ID: 17997145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy.
    Kelly MG; O'malley DM; Hui P; McAlpine J; Yu H; Rutherford TJ; Azodi M; Schwartz PE
    Gynecol Oncol; 2005 Sep; 98(3):353-9. PubMed ID: 16005947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Papillary serous adenocarcinoma of the uterine cervix: a case report.
    Yüksel H; Sezer SD; Küçük M; Riza Obadaşi A; Döger FK
    Eur J Gynaecol Oncol; 2011; 32(2):240-2. PubMed ID: 21614930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peritoneal disseminated recurrence and lung metastasis after surgery for stage IA uterine papillary serous carcinoma of the endometrium: a case report.
    Kanayama S; Yamada Y; Haruta S; Naruse K; Furukawa N; Kawaguchi R; Yoshida S; Sakata M; Sado T; Kitanaka T; Oi H; Kobayashi H
    Arch Gynecol Obstet; 2008 Sep; 278(3):277-80. PubMed ID: 18193438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation of PPP2R1A: a new clue in unveiling the pathogenesis of uterine serous carcinoma.
    Shih IeM; Wang TL
    J Pathol; 2011 May; 224(1):1-4. PubMed ID: 21432855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD44 expression in papillary serous endometrial carcinoma.
    Hosford S; Elliott J; Ma ZW; Majeste R; Dubeshter B
    Int J Gynecol Cancer; 2003; 13(4):480-4. PubMed ID: 12911725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted therapy in the treatment of uterine serous carcinoma.
    Schwab CL; Santin AD
    Pharmacogenomics; 2015 Jan; 16(2):97-9. PubMed ID: 25616096
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.